Inventinve Medicines - Costly Miracles or Mayhem of the Modern Science
Inventinve Medicines - Costly Miracles or Mayhem of the Modern Science

Summary/Abstract: The aim of paper is to evaluate the complexity of research and development process in world pharmaceutical industry. We found out that considerable declines in research and development productivity challenge the sustainability of the current business model of world pharmaceutical companies. We may stipulate that one of the major drivers of decline in the last decade in pharmaceutical industry has been the increased rate of failure in research and development. We found out that number of new pharmaceutical products having been launched in the last years has considerably lowered. The research and development of a new drug is highly complex, demanding, costly and risky process. We proved this in our research by presenting a significant case of pharmaceutical product branded Zimulti (rimonabant). We may conclude that in endeavour to bring new drugs to world markets, pharmaceutical companies tend to search for new business models, where consolidation has predominantly prevailed.

• Details
• Contents